NCT03556475View on ClinicalTrials.gov

Development of AECOPD Identification Tool (DETECT Study)

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

January 18, 2021

Study Completion Date

January 18, 2021

Conditions
Acute Exacerbations of COPD
Trial Locations (7)

110001

Research Site, Shenyang

200433

Research Site, Shanghai

510515

Research Site, Guangzhou

710061

Research Site, Xi'an

Unknown

Research Site, Beijing

Research Site, Changsha

Research Site, Xinxiang

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY